Literature DB >> 1449185

Radiographic differential diagnosis of petrous apex lesions.

R K Jackler1, D A Parker.   

Abstract

As a consequence of improved diagnostic imaging modalities, otologists have encountered a steadily increasing number of petrous apex lesions in recent years. Contemporary imaging techniques not only provide precise anatomic localization of the lesion, but also are able to suggest specific tissue diagnoses in the majority of cases. Computed tomography (CT), by virtue of its sensitivity and low false-positive rate, is the screening examination of choice in a patient suspected of having a petrous apex lesion. Once a lesion is identified, it is often necessary to obtain a combination of CT and magnetic resonance imaging (MRI). Computed tomography is important in the detection of osseous erosion as well as in the evaluation of the extent of pneumatization and marrow formation. It also provides important details about potential surgical routes to this relatively inaccessible region. Magnetic resonance imaging provides information about the composition of the lesion that cannot be readily discerned on CT scans. In the great majority of cases, it is capable of differentiating between petrous apicitis, cholesterol granuloma, osteomyelitis, cholesteatoma, and neoplasms such as schwannoma, meningioma, chondroma, and chordoma. In the interpretation of MRI scans, a familiarity with the typical appearance of the lesions that affect the petrous apex on T1-weighted, T2-weighted, and gadolinium-enhanced images is essential. A combination of MRI and CT scanning is also necessary to evaluate normal anatomic variations, such as giant air cells and asymmetric bone marrow, which may at times, on MRI alone, simulate pathologic conditions.

Entities:  

Mesh:

Year:  1992        PMID: 1449185

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  19 in total

1.  Cholesteatoma of the petrous bone: the crucial role of diffusion-weighted MRI.

Authors:  Tsuyoshi Yoshida; Ken Ito; Nodoka Adachi; Tatsuya Yamasoba; Kenji Kondo; Kimitaka Kaga
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-09-11       Impact factor: 2.503

2.  The middle fossa transpetrous approach: experience with 13 cases.

Authors:  P S Nassif; H L Hankinson; K L Horn
Journal:  Skull Base Surg       Date:  1997

Review 3.  [Inflammatory lesions of the brainstem and the cerebellopontine angle].

Authors:  J Lutz; L Jäger
Journal:  Radiologe       Date:  2006-03       Impact factor: 0.635

4.  Multidisciplinary care of a paediatric patient with Gradenigo's syndrome.

Authors:  Noor Janjua; Mohammed Bajalan; Samantha Potter; Andrea Whitney; Fabian Sipaul
Journal:  BMJ Case Rep       Date:  2016-02-25

5.  Primary schwannoma of the petrous apex.

Authors:  K L Horn; H L Hankinson; A J Nissen; S L McDaniel
Journal:  Skull Base Surg       Date:  1995

6.  Petrous apex lesions.

Authors:  R G Amedee; G J Gianoli; W J Mann
Journal:  Skull Base Surg       Date:  1994

7.  Intraosseous schwannoma of the petrous apex.

Authors:  Christopher Goiney; Rita Bhatia; Kevin Auerbach; Michael Norenberg; Jacques Morcos
Journal:  J Radiol Case Rep       Date:  2011-11-01

8.  Gradenigo's syndrome with lateral venous sinus thrombosis: successful conservative treatment.

Authors:  Alessandra Scardapane; Marianna Del Torto; Manuela Nozzi; Concettina Elio; Luciana Breda; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2009-08-21       Impact factor: 3.183

9.  Percutaneous access to the petrous apex in vitro using customized micro-stereotactic frames based on image-guided surgical technology.

Authors:  George B Wanna; Ramya Balachandran; Omid Majdani; Jason Mitchell; Robert F Labadie
Journal:  Acta Otolaryngol       Date:  2009-08-25       Impact factor: 1.494

10.  Bilateral petrous internal carotid artery pseudoaneurysms presenting with sensorineural hearing loss.

Authors:  Catherine J Hwang; Gul Moonis; Robert W Hurst; Neil Hockstein; Douglas Bigelow
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.